Genetic immunization converts the Trypanosoma cruzi B-cell mitogen proline racemase to an effective immunogen

Infection and Immunity

Volumn 78, Issue 2, 2010, Pages 810-822

  Bryan, Marianne A ^a   Norris, Karen A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; COMPLEMENT REGULATORY PROTEIN; DNA; IMMUNOGLOBULIN G; INTERLEUKIN 10; MITOGENIC AGENT; PROLINE RACEMASE; RACEMASE; RECOMBINANT PROTEIN; RECOMBINANT TRYPANOSOMA CRUZI PROLINE RACEMASE PROTEIN; REGULATOR PROTEIN; TRYPANOSOMA CRUZI VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; GENETIC IMMUNIZATION; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SPLEEN CELL; TRYPANOSOMA CRUZI;

AMINO ACID ISOMERASES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BIOLISTICS; BLOTTING, WESTERN; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MITOGENS; MOLECULAR SEQUENCE DATA; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI;

EID: 76749086166     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00926-09     Document Type: Article

References (71)

1. Abrahamsohn, I. A., and R. L. Coffman. 1996. Trypanosoma cruzi: IL-10, TNF, IFN-γ, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84:231-244.
2. Agematsu, K., H. Nagumo, Y. Oguchi, T. Nakazawa, K. Fukushima, K. Yasui, S. Ito, T. Kobata, C. Morimoto, and A. Komiyama. 1998. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 91:173-180.
3. Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr. Opin. Immunol. 20:149-157.
4. Aosai, F., M. Chen, H. K. Kang, H. S. Mun, K. Norose, L. X. Piao, M. Kobayashi, O. Takeuchi, S. Akira, and A. Yano. 2002. Toxoplasma gondiiderived heat shock protein HSP70 functions as a B cell mitogen. Cell Stress Chaperones 7:357-364.
5. Beucher, M., W. S. Meira, V. Zegarra, L. M. Galvao, E. Chiari, and K. A. Norris. 2003. Expression and purification of functional, recombinant Trypanosoma cruzi complement regulatory protein. Protein Expr. Purif. 27: 19-26.
6. Boscardin, S. B., S. S. Kinoshita, A. E. Fujimura, and M. M. Rodrigues. 2003. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect. Immun. 71:2744-2757.
7. Brener, Z. 1980. Immunity to Trypanosoma cruzi. Adv. Parasitol. 18:247-292.
8. Chamond, N., M. Goytia, N. Coatnoan, J. C. Barale, A. Cosson, W. M. Degrave, and P. Minoprio. 2005. Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity. Mol. Microbiol. 58:46-60.
9. Chamond, N., C. Gregoire, N. Coatnoan, C. Rougeot, L. H. Freitas-Junior, J. F. da Silveira, W. M. Degrave, and P. Minoprio. 2003. Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures. J. Biol. Chem. 278:15484-15494.
10. Costa, F., G. Franchin, V. L. Pereira-Chioccola, M. Ribeirao, S. Schenkman, and M. M. Rodrigues. 1998. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16:768-774.
11. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771-5777.
12. Coutinho, A., E. Gronowicz, W. W. Bullock, and G. Moller. 1974. Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J. Exp. Med. 139:74-92.
13. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111-122.
14. Crotty, S., E. N. Kersh, J. Cannons, P. L. Schwartzberg, and R. Ahmed. 2003. SAP is required for generating long-term humoral immunity. Nature 421: 282-287.
15. Cunningham, D. S., R. E. Kuhn, and E. C. Rowland. 1978. Suppression of humoral responses during Trypanosoma cruzi infections in mice. Infect. Immun. 22:155-160.
16. Dinis, M., D. Tavares, A. J. M. M. Fonseca, R. Faria, A. Ribeiro, A. M. Silverio Cabrita, and P. Ferreira. 2004. Therapeutic vaccine against Streptococcus sobrinus-induced caries. J. Dental Res. 83:354-358.
17. Fairfax, K. A., A. Kallies, S. L. Nutt, and D. M. Tarlinton. 2008. Plasma cell development: from B-cell subsets to long-term survival niches. Semin. Immunol. 20:49-58.
18. Ferreira, P., A. Bras, D. Tavares, M. Vilanova, A. Ribeiro, A. Videira, and M. Arala-Chaves. 1997. Purification, and biochemical and biological characterization of an immunosuppressive and lymphocyte mitogenic protein secreted by Streptococcus sobrinus. Int. Immunol. 9:1735-1743.
19. Fralish, B. H., and R. L. Tarleton. 2003. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine 21:3070-3080.
20. Fujimura, A. E., S. S. Kinoshita, V. L. Pereira-Chioccola, and M. M. Rodrigues. 2001. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 69:5477-5486.
21. Gunn, K. E., and J. W. Brewer. 2006. Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity. J. Immunol. 177:3791-3798.
22. He, B., X. Qiao, P. J. Klasse, A. Chiu, A. Chadburn, D. M. Knowles, J. P. Moore, and A. Cerutti. 2006. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 176:3931-3941.
23. Kirchhoff, L. V. 2001. American trypanosomiasis (Chagas' disease), p. 335-353. In S. G. R. Pearson (ed.), Principles and practice of clinical parasitology. John Wiley & Sons Ltd., New York, NY.
24. LeBien, T. W., and T. F. Tedder. 2008. B lymphocytes: how they develop and function. Blood 112:1570-1580.
25. Lima, M., A. Bandeira, D. Portnoi, A. Ribeiro, and M. A. Chaves. 1992. Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3′EP-Si, or P90) produced by Streptococcus intermedius. Infect. Immun. 60:3571-3578.
26. Lund, F. E. 2008. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 20:332-338.
27. Madan, R., F. Demircik, S. Surianarayanan, J. L. Allen, S. Divanovic, A. Trompette, N. Yogev, Y. Gu, M. Khodoun, D. Hildeman, N. Boespflug, M. B. Fogolin, L. Grobe, M. Greweling, F. D. Finkelman, R. Cardin, M. Mohrs, W. Muller, A. Waisman, A. Roers, and C. L. Karp. 2009. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183: 2312-2320.
28. Madureira, P., M. Baptista, M. Vieira, V. Magalhaes, A. Camelo, L. Oliveira, A. Ribeiro, D. Tavares, P. Trieu-Cuot, M. Vilanova, and P. Ferreira. 2007. Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J. Immunol. 178:1379-1387.
29. Malkiel, S., C. J. Kuhlow, P. Mena, and J. L. Benach. 2009. The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease Borrelia. J. Immunol. 182:498-506.
30. Meyer-Bahlburg, A., A. D. Bandaranayake, S. F. Andrews, and D. J. Rawlings. 2009. Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J. Immunol. 182:4065-4075.
31. Minoprio, P. 2002. Impact of polyclonal lymphocyte responses on parasite evasion and persistence, p. 101-107. In J. M. Kelly (ed.), Molecular mechanisms of pathogenesis in Chagas disease. Landes Bioscience, Georgetown, TX.
32. Minoprio, P., A. Coutinho, S. Spinella, and M. Hontebeyrie-Joskowicz. 1991. Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease. Int. Immunol. 3:427-433.
33. Minoprio, P. M., H. Eisen, L. Forni, M. R. D'Imperio Lima, M. Joskowicz, and A. Coutinho. 1986. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scand. J. Immunol. 24:661-668.
34. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176:705-710.
35. Montes, C. L., E. V. Acosta-Rodriguez, M. C. Merino, D. A. Bermejo, and A. Gruppi. 2007. Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host? J. Leukoc. Biol. 82:1027-1032.
36. Montes, C. L., E. I. Zuniga, J. Vazquez, C. Arce, and A. Gruppi. 2002. Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation. Clin. Exp. Immunol. 127:27-36.
37. Norris, K. A., J. E. Schrimpf, and M. J. Szabo. 1997. Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein. Infect. Immun. 65:349-357.
38. O'Connor, B. P., M. W. Gleeson, R. J. Noelle, and L. D. Erickson. 2003. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol. Rev. 194:61-76.
39. Oliver, A. M., F. Martin, G. L. Gartland, R. H. Carter, and J. F. Kearney. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27:2366-2374.
40. Payne, L. G., D. H. Fuller, and J. R. Haynes. 2002. Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma. Curr. Opin. Mol. Ther. 4:459-466.
41. Quanquin, N. M., C. Galaviz, D. L. Fouts, R. A. Wrightsman, and J. E. Manning. 1999. Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity. Infect. Immun. 67:4603-4612.
42. Radwanska, M., P. Guirnalda, C. De Trez, B. Ryffel, S. Black, and S. Magez. 2008. Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathog. 4:e1000078.
43. Reed, S., C. Brownell, D. Russo, J. Silva, K. Grabstein, and P. Morrissey. 1994. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153:3135-3140.
44. Reina-San-Martin, B., A. Cosson, and P. Minoprio. 2000. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitol. Today 16:62-67.
45. Reina-San-Martin, B., W. Degrave, C. Rougeot, A. Cosson, N. Chamond, A. Cordeiro-Da-Silva, M. Arala-Chaves, A. Coutinho, and P. Minoprio. 2000. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat. Med. 6:890-897.
46. Rico, A. I., N. Girones, M. Fresno, C. Alonso, and J. M. Requena. 2002. The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones 7:339-346.
47. Robinson, H. L., and C. A. Torres. 1997. DNA vaccines. Semin. Immunol. 9:271-283.
48. Rott, O., J. Charreire, and E. Cash. 1996. Influenza A virus hemagglutinin is a B cell-superstimulatory lectin. Med. Microbiol. Immunol. 184:185-193.
49. Russo, M., P. Minoprio, A. Coutinho, and M. Hontebeyrie-Joskowicz. 1988. Depletion of L3T4+ T lymphocytes during acute Trypanosoma cruzi infection abolish macrophage and B lymphocyte activation but not tissue inflammatory reaction. Mem. Inst. Oswaldo Cruz 83(Suppl. 1):527-538.
50. Sangster, M. Y., D. J. Topham, S. D'Costa, R. D. Cardin, T. N. Marion, L. K. Myers, and P. C. Doherty. 2000. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J. Immunol. 164:1820-1828.
51. Schijman, A. G., C. A. Vigliano, R. J. Viotti, J. M. Burgos, S. Brandariz, B. E. Lococo, M. I. Leze, H. A. Armenti, and M. J. Levin. 2004. Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic Chagas heart disease. Am. J. Trop. Med. Hyg. 70:210-220.
52. Schnapp, A. R., C. S. Eickhoff, D. Sizemore, R. Curtiss III, and D. F. Hoft. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect. Immun. 70:5065-5074.
53. Sepulveda, P., M. Hontebeyrie, P. Liegeard, A. Mascilli, and K. A. Norris. 2000. DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Infect. Immun. 68:4986-4991.
54. Silva, J., P. Morrissey, K. Grabstein, K. Mohler, D. Anderson, and S. Reed. 1992. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169-174.
55. Slifka, M. K., and R. Ahmed. 1996. Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay. J. Immunol. Methods 199:37-46.
56. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-372.
57. Slifka, M. K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895-1902.
58. Soares, R., P. Ferreira, M. M. Santarem, M. Teixeira da Silva, and M. Arala-Chaves. 1990. Low T- and B-cell reactivity is an apparently paradoxical request for murine immunoprotection against Streptococcus mutans. Murine protection can be achieved by immunization against a B-cell mitogen produced by these bacteria. Scand. J. Immunol. 31:361-366.
59. Spera, J. M., J. E. Ugalde, J. Mucci, D. J. Comerci, and R. A. Ugalde. 2006. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc. Natl. Acad. Sci. USA 103:16514-16519.
60. Suarez, F., O. Lortholary, O. Hermine, and M. Lecuit. 2006. Infectionassociated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107:3034-3044.
61. Tavares, D., P. Ferreira, and M. Arala-Chaves. 2003. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein. Microbiology 149:333-339.
62. Tavares, D., P. Ferreira, M. Vilanova, A. Videira, and M. Arala-Chaves. 1995. Immunoprotection against systemic candidiasis in mice. Int. Immunol. 7:785-796.
63. Tavares, D., A. Salvador, P. Ferreira, and M. Arala-Chaves. 1993. Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host. Infect. Immun. 61: 1881-1888.
64. Teixeira, A. R., G. Teixeira, V. Macedo, and A. Prata. 1978. Acquired cellmediated immunodepression in acute Chagas' disease. J. Clin. Invest. 62: 1132-1141.
65. Wang, S., C. Zhang, L. Zhang, J. Li, Z. Huang, and S. Lu. 2008. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 26: 2100-2110.
66. Watanabe, K., H. Kumada, F. Yoshimura, and T. Umemoto. 1996. The induction of polyclonal B-cell activation and interleukin-1 production by the 75-kDa cell surface protein from Porphyromonas gingivalis in mice. Arch. Oral Biol. 41:725-731.
67. Wizel, B., N. Garg, and R. L. Tarleton. 1998. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:5073-5081.
68. Wizel, B., M. Nunes, and R. L. Tarleton. 1997. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J. Immunol. 159:6120-6130.
69. Won, W.-J., and J. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168:5605-5611.
70. Wrightsman, R. A., K. A. Luhrs, D. Fouts, and J. E. Manning. 2002. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells. Parasite Immunol. 24:401-412.
71. Yanaba, K., J.-D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder. 2009. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182:7459-7472.